Evolution of surgical modalities in the management of rhinophyma: our experience.

Autor: Goh M; Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK. Electronic address: meigoh@nhs.net., Gönen ZB; Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK; Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey., Sayan A; Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK., Ilankovan V; Oral and Maxillofacial Unit, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, BH15 2JB, UK.
Jazyk: angličtina
Zdroj: The British journal of oral & maxillofacial surgery [Br J Oral Maxillofac Surg] 2021 Feb; Vol. 59 (2), pp. 222-227. Date of Electronic Publication: 2020 Aug 22.
DOI: 10.1016/j.bjoms.2020.08.071
Abstrakt: Rhinophyma is a progressive disease of the nose, which is characterised by skin thickening and sebaceous hyperplasia. Patients with rhinophyma are often stigmatised due to worsening disfigurement of their nose. This can also result in functional impairment such as reduced nasal patency. Severe cases of rhinophyma are best managed with varied surgical interventions, as there is no clear 'gold standard' treatment that has been described. We present our experiences in the management of rhinophyma and the evolution of treatment modalities that have been employed over a nine-year period.
(Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: